Search
Exact matches only
Search in title
Search in content
Search in comments
Search in excerpt
Search in posts
Search in pages
Search in groups
Search in users
Search in forums
Filter by Custom Post Type
Filter by Categories
Filter by Report Categories
Advance Interior Materials
Agriculture Industry
Agrochemicals & fertilizers
Animal feed and feed additives
Automotive Sector
Automotive & Transportation
Biotechnology
Building & Construction
Building & Construction Materials
Electronics & Semiconductors
Electronic Devices
Electronic Security
Energy & Resources
Alternative Energy
Distribution & Utilities
Power generation and storage
Food & Beverage
Food Additives and Nutricosmetics
Life Sciences
Healthcare
Wellness
Personal Care & Cosmetics
Materials & Chemicals
Advanced Materials
Advanced Materials (Green Building Materials)
Ceramic & Fiber
Coatings & printing inks
Organic Chemicals
Paints
Petrochemicals
Plastics
Polymers & Resins
Renewable Chemicals
Specialty & Fine Chemicals
Specialty glass
Specialty Polymer
Medical Devices
Pharmaceuticals
Clinic Diagnostics
Technology & Media
Communication Infrastructure
Communication Services
HVAC and Construction
Next Generation Technologies
Textiles
Smart Textiles
{ "homeurl": "https://www.marketresearchandstatistics.com/", "resultstype": "vertical", "resultsposition": "hover", "itemscount": 4, "imagewidth": 70, "imageheight": 70, "resultitemheight": "auto", "showauthor": 0, "showdate": 0, "showdescription": 1, "charcount": 3, "noresultstext": "No results!", "didyoumeantext": "Did you mean:", "defaultImage": "https://www.marketresearchandstatistics.com/wp-content/plugins/ajax-search-pro/img/default.jpg", "highlight": 0, "highlightwholewords": 1, "openToBlank": 0, "scrollToResults": 0, "resultareaclickable": 1, "autocomplete": { "enabled": 1, "googleOnly": 0, "lang": "en" }, "triggerontype": 1, "triggeronclick": 1, "triggeronreturn": 1, "triggerOnFacetChange": 0, "overridewpdefault": 0, "redirectonclick": 1, "redirectClickTo": "results_page", "redirect_on_enter": 1, "redirectEnterTo": "results_page", "redirect_url": "?s={phrase}", "more_redirect_url": "?s={phrase}", "settingsimagepos": "left", "settingsVisible": 0, "hresulthidedesc": "0", "prescontainerheight": "400px", "pshowsubtitle": "0", "pshowdesc": "1", "closeOnDocClick": 1, "iifNoImage": "description", "iiRows": 2, "iiGutter": 5, "iitemsWidth": 200, "iitemsHeight": 200, "iishowOverlay": 1, "iiblurOverlay": 1, "iihideContent": 1, "loaderLocation": "auto", "analytics": 0, "analyticsString": "", "aapl": { "on_click": 0, "on_magnifier": 0, "on_enter": 0, "on_typing": 0 }, "compact": { "enabled": 0, "width": "100%", "closeOnMagnifier": 1, "closeOnDocument": 0, "position": "static", "overlay": 0 }, "animations": { "pc": { "settings": { "anim" : "fadedrop", "dur" : 300 }, "results" : { "anim" : "fadedrop", "dur" : 300 }, "items" : "fadeInDown" }, "mob": { "settings": { "anim" : "fadedrop", "dur" : 300 }, "results" : { "anim" : "fadedrop", "dur" : 300 }, "items" : "voidanim" } }, "autop": { "state": "disabled", "phrase": "", "count": 10 } }

SK Biopharmaceuticals Co., Ltd. – Product Pipeline Review – 2015

$1,500

Global Markets Direct’s, ‘SK Biopharmaceuticals Co., Ltd. – Product Pipeline Review – 2015’, provides an overview of the SK Biopharmaceuticals Co., Ltd.’s pharmaceutical research and development focus. This report provides comprehensive information on the current therapeutic developmental pipeline of SK Biopharmaceuticals Co., Ltd.’s, complete with comparative analysis.

Total Pages: 48

sk-biopharmaceuticals-co-ltd-product-pipeline-review-2015
600
#9e2f22

Global Markets Direct’s, ‘SK Biopharmaceuticals Co., Ltd. - Product Pipeline Review - 2015’, provides an overview of the SK Biopharmaceuticals Co., Ltd.’s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of SK Biopharmaceuticals Co., Ltd.’s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct’s team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides brief overview of SK Biopharmaceuticals Co., Ltd. including business description, key information and facts, and its locations and subsidiaries
- The report reviews current pipeline of SK Biopharmaceuticals Co., Ltd.’s human therapeutic division and enlists all their major and minor projects
- The report features product description and descriptive mechanism of action for key pipeline products along with the product’s developmental history and major milestones
- Special feature on out-licensed and partnered product portfolio
- The report summarizes all the dormant and discontinued pipeline projects
- Latest company statement
- Latest news and deals relating to the SK Biopharmaceuticals Co., Ltd.’s pipeline products

Reasons to buy

- Evaluate SK Biopharmaceuticals Co., Ltd.’s strategic position with total access to detailed information on its product pipeline
- Assess the growth potential of SK Biopharmaceuticals Co., Ltd. in its therapy areas of focus
- Identify new drug targets and therapeutic classes in the SK Biopharmaceuticals Co., Ltd.’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
- Develop strategic initiatives by understanding the focus areas of SK Biopharmaceuticals Co., Ltd. and exploit collaboration and partnership opportunities
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Plan mergers and acquisitions effectively by identifying the most promising pipeline of SK Biopharmaceuticals Co., Ltd.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
- Explore the dormant and discontinued projects of SK Biopharmaceuticals Co., Ltd. and identify potential opportunities in those areas
- Avoid Intellectual Property Rights related issues

Table of Contents
Table of Contents 2
List of Tables 5
List of Figures 5
SK Biopharmaceuticals Co., Ltd. Snapshot 6
SK Biopharmaceuticals Co., Ltd. Overview 6
Key Information 6
Key Facts 6
SK Biopharmaceuticals Co., Ltd. - Research and Development Overview 7
Key Therapeutic Areas 7
SK Biopharmaceuticals Co., Ltd. - Pipeline Review 10
Pipeline Products by Stage of Development 10
Pipeline Products - Monotherapy 11
SK Biopharmaceuticals Co., Ltd. - Pipeline Products Glance 12
SK Biopharmaceuticals Co., Ltd. - Late Stage Pipeline Products 12
Phase III Products/Combination Treatment Modalities 12
SK Biopharmaceuticals Co., Ltd. - Clinical Stage Pipeline Products 13
Phase II Products/Combination Treatment Modalities 13
Phase I Products/Combination Treatment Modalities 14
SK Biopharmaceuticals Co., Ltd. - Early Stage Pipeline Products 15
IND/CTA Filed Products/Combination Treatment Modalities 15
Preclinical Products/Combination Treatment Modalities 16
Discovery Products/Combination Treatment Modalities 17
SK Biopharmaceuticals Co., Ltd. - Drug Profiles 18
SKL-N05 18
Product Description 18
Mechanism of Action 18
R&D Progress 18
YKP-3089 20
Product Description 20
Mechanism of Action 20
R&D Progress 20
relenopride hydrochloride 22
Product Description 22
Mechanism of Action 22
R&D Progress 22
carisbamate 23
Product Description 23
Mechanism of Action 23
R&D Progress 23
SKL-15508 25
Product Description 25
Mechanism of Action 25
R&D Progress 25
SKL-A4R 26
Product Description 26
Mechanism of Action 26
R&D Progress 26
SKL-PD 27
Product Description 27
Mechanism of Action 27
R&D Progress 27
SKL-PSY 28
Product Description 28
Mechanism of Action 28
R&D Progress 28
N-2 29
Product Description 29
Mechanism of Action 29
R&D Progress 29
SKL-16036 30
Product Description 30
Mechanism of Action 30
R&D Progress 30
SKL-G 31
Product Description 31
Mechanism of Action 31
R&D Progress 31
Small Molecule for Multiple Sclerosis 32
Product Description 32
Mechanism of Action 32
R&D Progress 32
Small Molecule for Neuropathic Pain 33
Product Description 33
Mechanism of Action 33
R&D Progress 33
Small Molecule for Tauopathies and Alzheimer's Disease 34
Product Description 34
Mechanism of Action 34
R&D Progress 34
Small Molecule to Inhibit TDP-43 for Amyotrophic Lateral Sclerosis 35
Product Description 35
Mechanism of Action 35
R&D Progress 35
SK Biopharmaceuticals Co., Ltd. - Pipeline Analysis 36
SK Biopharmaceuticals Co., Ltd. - Pipeline Products by Target 36
SK Biopharmaceuticals Co., Ltd. - Pipeline Products by Route of Administration 38
SK Biopharmaceuticals Co., Ltd. - Pipeline Products by Molecule Type 39
SK Biopharmaceuticals Co., Ltd. - Pipeline Products by Mechanism of Action 40
SK Biopharmaceuticals Co., Ltd. - Recent Pipeline Updates 41
SK Biopharmaceuticals Co., Ltd. - Dormant Projects 44
SK Biopharmaceuticals Co., Ltd. - Discontinued Pipeline Products 45
Discontinued Pipeline Product Profiles 45
carisbamate 45
SK Biopharmaceuticals Co., Ltd. - Locations And Subsidiaries 46
Head Office 46
Other Locations & Subsidiaries 46
Appendix 47
Methodology 47
Coverage 47
Secondary Research 47
Primary Research 47
Expert Panel Validation 47
Contact Us 47
Disclaimer 48

List of Tables
SK Biopharmaceuticals Co., Ltd., Key Information 6
SK Biopharmaceuticals Co., Ltd., Key Facts 6
SK Biopharmaceuticals Co., Ltd. - Pipeline by Indication, 2015 8
SK Biopharmaceuticals Co., Ltd. - Pipeline by Stage of Development, 2015 10
SK Biopharmaceuticals Co., Ltd. - Monotherapy Products in Pipeline, 2015 11
SK Biopharmaceuticals Co., Ltd. - Phase III, 2015 12
SK Biopharmaceuticals Co., Ltd. - Phase II, 2015 13
SK Biopharmaceuticals Co., Ltd. - Phase I, 2015 14
SK Biopharmaceuticals Co., Ltd. - IND/CTA Filed, 2015 15
SK Biopharmaceuticals Co., Ltd. - Preclinical, 2015 16
SK Biopharmaceuticals Co., Ltd. - Discovery, 2015 17
SK Biopharmaceuticals Co., Ltd. - Pipeline by Target, 2015 37
SK Biopharmaceuticals Co., Ltd. - Pipeline by Route of Administration, 2015 38
SK Biopharmaceuticals Co., Ltd. - Pipeline by Molecule Type, 2015 39
SK Biopharmaceuticals Co., Ltd. - Pipeline Products by Mechanism of Action, 2015 40
SK Biopharmaceuticals Co., Ltd. - Recent Pipeline Updates, 2015 41
SK Biopharmaceuticals Co., Ltd. - Dormant Developmental Projects,2015 44
SK Biopharmaceuticals Co., Ltd. - Discontinued Pipeline Products, 2015 45
SK Biopharmaceuticals Co., Ltd., Other Locations 46
SK Biopharmaceuticals Co., Ltd., Subsidiaries 46

List of Figures
SK Biopharmaceuticals Co., Ltd. - Pipeline by Top 10 Indication, 2015 8
SK Biopharmaceuticals Co., Ltd. - Pipeline by Stage of Development, 2015 10
SK Biopharmaceuticals Co., Ltd. - Monotherapy Products in Pipeline, 2015 11
SK Biopharmaceuticals Co., Ltd. - Pipeline by Top 10 Target, 2015 36
SK Biopharmaceuticals Co., Ltd. - Pipeline by Top 10 Route of Administration, 2015 38
SK Biopharmaceuticals Co., Ltd. - Pipeline by Top 10 Molecule Type, 2015 39
SK Biopharmaceuticals Co., Ltd. - Pipeline Products by Top 10 Mechanism of Action, 2015 40


LICENSE TYPE